McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Andrew Williams is quoted in an August 8, 2013 online edition of World Intellectual Property Review in an article entitled, “Myriad patent suit enters antitrust territory.” Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims. View the article